Marisa Di Seri

1.2k total citations · 1 hit paper
13 papers, 943 citations indexed

About

Marisa Di Seri is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marisa Di Seri has authored 13 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marisa Di Seri's work include Cancer Treatment and Pharmacology (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Marisa Di Seri is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Marisa Di Seri collaborates with scholars based in Italy, United States and Switzerland. Marisa Di Seri's co-authors include Francesco Giuliani, Massimo Lopez, Biagio Agostara, G Paoletti, A. Misino, Stefano Cordio, Vittorio Gebbia, Luigi Manzione, Michele Caruso and S. Romito and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Annals of Thoracic Surgery.

In The Last Decade

Marisa Di Seri

13 papers receiving 901 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale

2005 586 citations Giuseppe Colucci, Vittorio Gebbia et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marisa Di Seri Italy	9	631	341	260	246	149	13	943
Ferrán Losa Spain	17	939 1.5×	361 1.1×	300 1.2×	196 0.8×	23 0.2×	70	1.1k
Trevor Stanbury France	11	240 0.4×	336 1.0×	172 0.7×	67 0.3×	96 0.6×	22	542
Lise Roca France	12	252 0.4×	382 1.1×	100 0.4×	57 0.2×	158 1.1×	33	724
Karl H. Link Germany	13	610 1.0×	248 0.7×	181 0.7×	103 0.4×	27 0.2×	21	738
Monica Niger Italy	16	469 0.7×	370 1.1×	323 1.2×	46 0.2×	65 0.4×	63	982
G Paoletti Italy	13	781 1.2×	152 0.4×	352 1.4×	232 0.9×	24 0.2×	29	977
F. Bertheault-Cvitkovic France	11	852 1.4×	258 0.8×	254 1.0×	405 1.6×	18 0.1×	15	1.0k
M. Michael Australia	9	590 0.9×	153 0.4×	238 0.9×	203 0.8×	16 0.1×	14	699
Hirotoshi Kobayashi Japan	21	1.6k 2.5×	1.2k 3.6×	711 2.7×	65 0.3×	45 0.3×	94	1.9k
S. Romito Italy	12	645 1.0×	153 0.4×	330 1.3×	223 0.9×	20 0.1×	23	871

Countries citing papers authored by Marisa Di Seri

Since Specialization

Citations

This map shows the geographic impact of Marisa Di Seri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisa Di Seri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisa Di Seri more than expected).

Fields of papers citing papers by Marisa Di Seri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marisa Di Seri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisa Di Seri. The network helps show where Marisa Di Seri may publish in the future.

Co-authorship network of co-authors of Marisa Di Seri

This figure shows the co-authorship network connecting the top 25 collaborators of Marisa Di Seri. A scholar is included among the top collaborators of Marisa Di Seri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marisa Di Seri. Marisa Di Seri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Sanctis, Rita De, Silvia Quadrini, Ester Del Signore, et al.. (2012). Capecitabine in elderly patients with metastatic breast cancer. IRIS Research product catalog (Sapienza University of Rome). 3 indexed citations

Sanctis, Rita De, Silvia Quadrini, Flavia Longo, et al.. (2012). Capecitabine in Elderly Patients with Metastatic Breast Cancer. Tumori Journal. 98(3). 303–307. 3 indexed citations

Rossi, Luigi, Enzo Veltri, Angelo Zullo, et al.. (2012). Bevacizumab Plus Chemotherapy in Metastatic Colorectal Cancer Patients Treated in Clinical Practice. Future Oncology. 8(9). 1193–1197. 5 indexed citations

Longo, Flavia, Giovanni Mansueto, Rita De Sanctis, et al.. (2010). Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy. Supportive Care in Cancer. 19(8). 1159–1164. 34 indexed citations

Giorgio, Angelo Di, Daniele Biacchi, Simone Sibio, et al.. (2008). Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer. 113(2). 315–325. 184 indexed citations

Santini, Daniele, Bruno Vincenzi, Gaia Schiavon, et al.. (2006). Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study. Cancer Chemotherapy and Pharmacology. 59(5). 613–620. 22 indexed citations

Tomao, Federica, Adriana Romiti, Federica Tomao, et al.. (2006). A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer. BMC Cancer. 6(1). 137–137. 13 indexed citations

Spinelli, Gian Paolo, Angelo Zullo, Adriana Romiti, et al.. (2006). Long-term survival in metastatic pancreatic cancer. A case report and review of the literature.. PubMed. 7(5). 486–91. 27 indexed citations

Santini, Daniele, Bruno Vincenzi, Annalisa La Cesa, et al.. (2005). Continuous Infusion of Oxaliplatin plus Chronomodulated Capecitabine in 5-Fluorouracil- and Irinotecan-Resistant Advanced Colorectal Cancer Patients. Oncology. 69(1). 27–34. 22 indexed citations

10.

Colucci, Giuseppe, Vittorio Gebbia, G Paoletti, et al.. (2005). Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale. Journal of Clinical Oncology. 23(22). 4866–4875. 586 indexed citations breakdown →

11.

Giorgio, Angelo Di, et al.. (2004). Lung cancer and skeletal muscle metastases. The Annals of Thoracic Surgery. 78(2). 709–711. 27 indexed citations

12.

Naglieri, Emanuele, G. Lelli, Francesco Morelli, et al.. (2003). Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinoma.. PubMed. 22(5). 3045–51. 12 indexed citations

13.

Romiti, Adriana, Giuseppe Tonini, Daniele Santini, et al.. (2003). Tolerability of Raltitrexed ('Tomudex') in elderly patients with colorectal cancer.. PubMed. 22(5). 3071–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact